ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

Clinical trial NCT04634357 · RECRUITING

Trial details

NCT number: NCT04634357
Sponsor: Eureka Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatoblastoma Hepatocellular Carcinoma (HCC)Liver Neoplasms Metastatic Liver Cancer Liver Cancer HEMNOS

Start date: 2022-07-19
Primary completion: 2027-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.